-
1
-
-
9244228971
-
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
-
The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
-
Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, Bucaneve G, Grokaert F, Kern WV, Klastersky J, Langenaeken I, Micozzi A, Padmos A, Paesmans M, Viscoli C, Glauser MP (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother 40: 1108-1115
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 1108-1115
-
-
Cometta, A.1
Calandra, T.2
Gaya, H.3
Zinner, S.H.4
De Bock, R.5
Del Favero, A.6
Bucaneve, G.7
Grokaert, F.8
Kern, W.V.9
Klastersky, J.10
Langenaeken, I.11
Micozzi, A.12
Padmos, A.13
Paesmans, M.14
Viscoli, C.15
Glauser, M.P.16
-
2
-
-
0034983570
-
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer
-
Fleischhack G, Hartmann C, Simon A, Wulff B, Havers W, Marklein G, Hasan C, Bode U (2001) Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 47: 841-853
-
(2001)
J Antimicrob Chemother
, vol.47
, pp. 841-853
-
-
Fleischhack, G.1
Hartmann, C.2
Simon, A.3
Wulff, B.4
Havers, W.5
Marklein, G.6
Hasan, C.7
Bode, U.8
-
3
-
-
0037087226
-
2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer
-
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34: 730-751
-
(2002)
Clin Infect Dis
, vol.34
, pp. 730-751
-
-
Hughes, W.T.1
Armstrong, D.2
Bodey, G.P.3
Bow, E.J.4
Brown, A.E.5
Calandra, T.6
Feld, R.7
Pizzo, P.A.8
Rolston, K.V.9
Shenep, J.L.10
Young, L.S.11
-
4
-
-
0026327445
-
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer
-
Riikonen P (1991) Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 10: 918-923
-
(1991)
Pediatr Infect Dis J
, vol.10
, pp. 918-923
-
-
Riikonen, P.1
-
5
-
-
0023911212
-
Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia
-
Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA (1988) Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 108: 30-35
-
(1988)
Ann Intern Med
, vol.108
, pp. 30-35
-
-
Rubin, M.1
Hathorn, J.W.2
Marshall, D.3
Gress, J.4
Steinberg, S.M.5
Pizzo, P.A.6
-
6
-
-
0031426830
-
Complications of central venous access devices in children with and without cancer
-
Tobiansky R, Lui K, Dalton DM, Shaw P, Martin H, Isaacs D (1997) Complications of central venous access devices in children with and without cancer. J Paediatr Child Health 33: 509-514
-
(1997)
J Paediatr Child Health
, vol.33
, pp. 509-514
-
-
Tobiansky, R.1
Lui, K.2
Dalton, D.M.3
Shaw, P.4
Martin, H.5
Isaacs, D.6
|